Company Filing History:
Years Active: 2008-2009
Title: Innovations and Contributions of Inventor Luis A G daCruz
Introduction
Luis A G daCruz is a notable inventor based in Toronto, Canada, recognized for his significant contributions to the field of cancer research. He holds three patents that focus on innovative methods for diagnosing and treating cancerous diseases. His work has the potential to impact the lives of many individuals affected by cancer.
Latest Patents
One of his latest patents is titled "Cytotoxicity mediation of cells evidencing surface expression of CD63." This invention relates to the diagnosis and treatment of cancerous diseases, particularly focusing on the mediation of cytotoxicity of primary and metastatic human tumor cells. It utilizes an isolated monoclonal antibody or cancerous disease modifying antibodies (CDMAB) in combination with chemotherapeutic agents to initiate a cytotoxic response in human tumors. The invention also includes binding assays that utilize the CDMAB.
Another significant patent is "Cytotoxicity mediation of cells evidencing surface expression of TROP-2." This invention presents a method for producing cancerous disease modifying antibodies through a novel screening paradigm. By segregating anti-cancer antibodies using cancer cell cytotoxicity as an endpoint, this process enables the production of antibodies for therapeutic and diagnostic purposes. These antibodies can aid in the staging and diagnosis of cancer and can be used to treat primary tumors and tumor metastases.
Career Highlights
Throughout his career, Luis A G daCruz has worked with prominent companies such as Arius Research, Inc. and Hoffmann-La Roche Inc. His experience in these organizations has contributed to his expertise in cancer research and antibody development.
Collaborations
Luis has collaborated with notable individuals in the field, including David S F Young and Helen P Findlay. These collaborations have likely enriched his research and innovation efforts.
Conclusion
Luis A G daCruz is a distinguished inventor whose work in cancer research has led to innovative patents that hold promise for improving cancer diagnosis and treatment. His contributions continue to advance the field and offer hope for better therapeutic options for patients.